DC-SIGN (Extracellular Domain) Blocking Peptide

DC-SIGN (Extracellular Domain) Blocking Peptide

Product No.: D289

[product_table name="All Top" skus="D289"]

- -
- -
Target
DC-SIGN
Product Type
Blocking Peptide

- -
- -
Select Product Size
- -
- -

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
This peptide sequence is located at amino acids 277 to 293 of Human DC-SIGN protein.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
17 amino acids near the extracellular domain of human DC-SIGN (ED).
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
DC-SIGN peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

References & Citations

1. Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA, Yuan J. Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-β. Nature 2000;403:98-103. 2. Mehmet H. Caspases find a new place to hide. Nature 2000;403:29-30 3. Van de Craen M, Vandenabeele P, Declercq W, Van den Brande I, Van Loo G, Molemans F, Schotte P, Van Criekinge W, Beyaert R, Fiers W. Characterization of seven murine caspase family members. FEBS Lett 1997;403:61-9 (WD1000) 4. Geijtenbeek TB, Kwon DS, Torensma R, et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell. 2000;100:587-97.
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.